Mishima, Japan

Takashi Deguchi

This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Deguchi. Retrieved from https://idiyas.com/inventor/takashi-deguchi-xwbu6t2q

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takashi Deguchi: Innovator in Pharmaceutical Science

Introduction

Takashi Deguchi is a prominent inventor based in Mishima, Japan. He has made significant contributions to the field of pharmaceutical science, particularly through his innovative work on novel physiologically active substances.

Latest Patents

Deguchi holds a patent for a novel physiologically active substance known as K-26. This patent describes a process for the preparation of K-26 and a pharmaceutical composition that includes this substance. K-26 is recognized for its potential use as a hypotensive agent, showcasing its importance in medical applications.

Career Highlights

Throughout his career, Takashi Deguchi has been associated with Kyowa Hakko Kogyo Co., Ltd., a leading company in the pharmaceutical industry. His work has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Deguchi has collaborated with notable colleagues, including Masayuki Yamato and Hiroshi Kase. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.

Conclusion

In summary, Takashi Deguchi is a distinguished inventor whose work on K-26 exemplifies the intersection of innovation and pharmaceutical science. His contributions continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…